POM operates an online platform connecting patients, healthcare providers, pharmacies, and suppliers within China's healthcare ecosystem. The company's core offering centers on chronic disease management, leveraging a digital infrastructure that enables telemedicine consultations, pharmaceutical retail, and supply chain coordination. Its internet hospital model facilitates remote patient-doctor interactions while simultaneously managing the distribution and sale of pharmaceutical products.
The company's revenue streams derive primarily from its B2C pharmaceutical retail portal and internet hospital operations. The platform functions as a marketplace intermediary, generating income through pharmaceutical sales, medical service transactions, and supply chain coordination services. Operations are concentrated in China, where the company addresses demand for remote healthcare access and medication delivery within the chronic disease treatment segment.
As of the latest available data, POM employs 156 full-time staff and maintains headquarters in Guangzhou, China. The company was established in 2010 and is incorporated in the Cayman Islands with a listing on Nasdaq. The organization operates at a modest scale relative to major pharmaceutical retailers, reflecting its specialized focus on digital-enabled chronic disease management within a specific geographic market.
No 10-K filings found.